Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Can Sangamo Biosciences, Inc. (SGMO) Win the Battle Against its Market Cap Peers?

Page 1 of 2

The 700+ hedge funds and money managers tracked by Insider Monkey have compiled and submitted their 13F filings for the third quarter, which unveiled their equity positions as of September 30. We went through these filings and identified the changes in hedge fund positions. Our extensive review of these public filings is finally over, so this article is set to reveal the smart money sentiment towards Sangamo Biosciences, Inc. (NASDAQ:SGMO).

Is Sangamo Biosciences, Inc. (NASDAQ:SGMO) a buy right now? The smart money is becoming less confident. The number of bullish hedge fund bets fell by 3 in recent months. SGMO was in 19 hedge funds’ portfolios at the end of September. There were 22 hedge funds in our database with SGMO holdings at the end of the previous quarter. At the end of this article we will also compare SGMO to other stocks including Donegal Group Inc (NASDAQ:DGICA), Cascade Bancorp (NASDAQ:CACB), and FormFactor, Inc. (NASDAQ:FORM) to get a better sense of its popularity.

Follow Sangamo Biosciences Inc (NASDAQ:SGMO)
Trade (NASDAQ:SGMO) Now!

In the 21st century investor’s toolkit there are several gauges investors put to use to value stocks. Some of the most innovative gauges are hedge fund and insider trading sentiment. Our researchers have shown that, historically, those who follow the top picks of the best fund managers can outclass the S&P 500 by a solid amount (see the details here).

With all of this in mind, we’re going to take a look at the latest action encompassing Sangamo Biosciences, Inc. (NASDAQ:SGMO).

What does the smart money think about Sangamo Biosciences, Inc. (NASDAQ:SGMO)?

At the end of the third quarter, a total of 19 of the hedge funds tracked by Insider Monkey held long positions in this stock, a 14% fall from one quarter earlier. With hedgies’ positions undergoing their usual ebb and flow, there exists an “upper tier” of noteworthy hedge fund managers who were increasing their holdings meaningfully (or had already accumulated large positions).

According to Insider Monkey’s hedge fund database, Baker Bros. Advisors, managed by Julian Baker and Felix Baker, holds the number one position in Sangamo Biosciences, Inc. (NASDAQ:SGMO). Baker Bros. Advisors has a $21.2 million position in the stock, comprising 0.2% of its 13F portfolio. On Baker Bros. Advisors’ heels is Millennium Management, led by Israel Englander, holding a $13.3 million position; less than 0.1% of its 13F portfolio is allocated to the company. Other hedge funds and institutional investors that are bullish encompass Peter Kolchinsky’s RA Capital Management, Phill Gross and Robert Atchinson’s Adage Capital Management, and Clifford Fox’s Columbus Circle Investors.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!